Cheryl Renz

2.1k total citations · 1 hit paper
27 papers, 1.5k citations indexed

About

Cheryl Renz is a scholar working on Infectious Diseases, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cheryl Renz has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Pharmacology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cheryl Renz's work include Pharmacology and Obesity Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pregnancy and Medication Impact (4 papers). Cheryl Renz is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pregnancy and Medication Impact (4 papers). Cheryl Renz collaborates with scholars based in United States, United Kingdom and Chile. Cheryl Renz's co-authors include Nick Finer, Richard A. Rode, Arya M. Sharma, Luc F. Van Gaal, Walmir Coutinho, Ian D. Caterson, Aldo P. Maggioni, Christian Torp‐Pedersen, W. P. T. James and Gillian Shepherd and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Biochemical Journal.

In The Last Decade

Cheryl Renz

25 papers receiving 1.4k citations

Hit Papers

Effect of Sibutramine on Cardiovascular Outcomes in Overw... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Renz United States 13 682 427 406 196 189 27 1.5k
M. González Sagrado Spain 24 277 0.4× 1.2k 2.7× 723 1.8× 98 0.5× 238 1.3× 163 2.7k
John H. Cavanaugh United States 23 222 0.3× 145 0.3× 313 0.8× 245 1.3× 81 0.4× 59 1.7k
Gary Ruoff United States 21 489 0.7× 325 0.8× 155 0.4× 68 0.3× 157 0.8× 77 1.6k
Gary J. Muirhead United Kingdom 17 121 0.2× 56 0.1× 424 1.0× 356 1.8× 130 0.7× 25 1.7k
Gary L. Lensmeyer United States 20 172 0.3× 126 0.3× 78 0.2× 69 0.4× 91 0.5× 37 1.6k
Sarita Bajaj India 21 81 0.1× 250 0.6× 816 2.0× 59 0.3× 192 1.0× 95 1.6k
B.‐E. Wiholm Sweden 23 217 0.3× 99 0.2× 371 0.9× 48 0.2× 236 1.2× 35 1.7k
Walter K. Kraft United States 29 161 0.2× 329 0.8× 43 0.1× 283 1.4× 371 2.0× 128 2.5k
Rocco C. Venuto United States 25 209 0.3× 252 0.6× 129 0.3× 92 0.5× 180 1.0× 103 2.1k
Jesper Madsen Denmark 15 455 0.7× 333 0.8× 1.3k 3.2× 109 0.6× 187 1.0× 28 2.0k

Countries citing papers authored by Cheryl Renz

Since Specialization
Citations

This map shows the geographic impact of Cheryl Renz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Renz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Renz more than expected).

Fields of papers citing papers by Cheryl Renz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Renz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Renz. The network helps show where Cheryl Renz may publish in the future.

Co-authorship network of co-authors of Cheryl Renz

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Renz. A scholar is included among the top collaborators of Cheryl Renz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Renz. Cheryl Renz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobson, Melanie H., et al.. (2024). Understanding willingness and barriers to participate in clinical trials during pregnancy and lactation: findings from a US study. BMC Pregnancy and Childbirth. 24(1). 504–504. 1 indexed citations
2.
Wyszynski, Diego F., et al.. (2024). Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug Safety. 47(9). 843–851.
3.
Gebel, Martin, Cheryl Renz, Lisa Rodríguez, et al.. (2024). A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry. Therapeutic Innovation & Regulatory Science. 58(4). 756–765. 3 indexed citations
4.
Wyszynski, Diego F., Mondira Bhattacharya, Óscar Martínez Pérez, et al.. (2023). The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug Safety. 46(3). 297–308. 3 indexed citations
5.
Wyszynski, Diego F., Aris T. Papageorghiou, Cheryl Renz, Torri D. Metz, & Sonia Hernández–Dı́az. (2023). The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations. Drug Safety. 47(3). 195–204. 1 indexed citations
6.
Renz, Cheryl, et al.. (2023). Klippel-Trenaunay-Weber syndrome: Oro-dental manifestations and management. International Journal of Surgery Case Reports. 110. 108690–108690. 1 indexed citations
7.
Lievano, Fabio, et al.. (2021). Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review. Drug Safety. 44(7). 733–742. 8 indexed citations
8.
Poulos, Christine, Ahmed M. Soliman, Cheryl Renz, Joshua Posner, & Sanjay K. Agarwal. (2019). Patient Preferences for Endometriosis Pain Treatments in the United States. Value in Health. 22(6). 728–738. 12 indexed citations
9.
Caterson, Ian D., Nick Finer, Walmir Coutinho, et al.. (2011). Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obesity and Metabolism. 14(6). 523–530. 108 indexed citations
10.
James, W. P. T., Ian D. Caterson, Walmir Coutinho, et al.. (2010). Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects. New England Journal of Medicine. 363(10). 905–917. 676 indexed citations breakdown →
12.
Finer, Nick, Donna H. Ryan, Cheryl Renz, & Ann C. Hewkin. (2005). Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients. Diabetes Obesity and Metabolism. 8(2). 206–213. 51 indexed citations
13.
Sáez‐Llorens, Xavier, Richard A. Rode, Edward Handelsman, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(3). 216–223. 5 indexed citations
14.
Sáez‐Llorens, Xavier, Richard A. Rode, Perry Gomez, et al.. (2003). Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 22(3). 216–223. 102 indexed citations
15.
Lynch, James P., Cheryl Renz, D. Laroche, & M. J. Moss. (2000). Value of baseline levels in assessing tryptase release. Inflammation Research. 49(S1). 23–24. 1 indexed citations
16.
Renz, Cheryl, et al.. (1999). Antihistamine prophylaxis permits rapid vancomycin infusion. Critical Care Medicine. 27(9). 1732–1737. 48 indexed citations
17.
Renz, Cheryl, et al.. (1998). Oral Antihistamines Reduce the Side Effects from Rapid Vancomycin Infusion. Anesthesia & Analgesia. 87(3). 681–685. 17 indexed citations
18.
Renz, Cheryl, D. Laroche, Henry A. Finn, et al.. (1998). Tryptase Levels Are Not Increased during Vancomycin-induced Anaphylactoid Reactions. Anesthesiology. 89(3). 620–625.. 56 indexed citations
19.
Renz, Cheryl, et al.. (1998). Histamine release during rapid vancomycin administration. Inflammation Research. 47(0). 69–70. 17 indexed citations
20.
Bell, Ellis, et al.. (1985). Negative co-operativity in glutamate dehydrogenase. Involvement of the 2-position in glutamate in the induction of conformational changes. Biochemical Journal. 225(1). 209–217. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026